亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Preservation of the Neuromuscular Junction (NMJ) After Traumatic Nerve Injury.

技術優勢
This technology can be used for treatment, as well as prevention of motor endplate degradation following nerve injury.
技術應用
This invention can be used to improve functional nerve recovery after injury. It can also be used for other therapeutic targets based on inhibition of MMP3, Wnt3a, and beta-catenin, and also to stabilize motor endplates.
詳細技術說明
Peripheral nerve injuries often produce permanent functional deficits despite surgical and medical management. This invention describes a method for preservation of the neuromuscular junction and treatment for peripheral nerve damage. Researchers at UC Irvine have demonstrated that overexpression of proteoglycan agrin results in motor end plate preservation. Furthermore, the researchers also showed that disruption of matrix metalloproteinase 3 (MMP3) via MMP3 knockout mice resulted in greater endplate efficacy and reinnervation compared to wildtype mice. Another study done by the inventor showed that after nerve transection injury, elevated levels of proteins Wnt3a and beta catenin are present at the post-synaptic muscle. The WNT/beta-catenin pathway serves as a therapeutic target to prevent motor endplate degradation follow injuries. The inventors propose a method for nerve injury treatment and prevention by targeting the known protein pathways.
*Abstract

This invention focuses on peripheral nerve injury prevention and treatment using antibodies, biomolecules, or small molecules.

*IP Issue Date
Jun 19, 2014
*Principal Investigation

Name: Ranjan Gupta

Department:

申請號碼
20140170162
其他

Tech ID/UC Case

25231/2013-227-2


Related Cases

2013-227-2

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備